Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Watching Sarepta Therapeutics; Shares Are Moving Higher; Traders Circulate LinkedIn Post From U.S. FDA Drug Regulator George Tidmarsh

Author: Benzinga Newsdesk | September 29, 2025 12:09pm

https://www.linkedin.com/posts/george-f-tidmarsh-972061b_cder-will-be-evaluating-surrogate-endpoints-activity-7378397083223056384-o69I?utm_source=li_share&utm_content=public_profile__posts&utm_medium=g_mb_web&utm_campaign=copy

Posted In: SRPT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist